FDA Advances Plan To Limit Nicotine, Critics Warn Of Black Market Risks

The Biden administration’s FDA is advancing a controversial plan to reduce nicotine levels in cigarettes, sparking fears of a black market surge. The rule, finalized for regulatory review on January 3, seeks to eliminate traditional tobacco products currently available.

Former ATF official Rich Marianos criticized the proposal, describing it as a windfall for criminal cartels. He warned that illicit groups, including cartels and international crime syndicates, could exploit the ban to smuggle high-nicotine products into the United States.
The proposal comes after a previously delayed effort to ban menthol cigarettes. Critics argue the broader plan is an eleventh-hour push by the Biden administration to enforce stricter regulations despite the potential for unintended consequences.

Marianos highlighted concerns about increased violence, noting that underground markets often result in turf wars. He emphasized that law enforcement could face additional challenges as these groups expand operations.

Ward Clark, writing for RedState, drew comparisons to Prohibition, arguing that such policies fail to eliminate demand but instead redirect it to illegal sources. Clark suggested the risks outweigh any potential benefits.

The FDA confirmed the proposal is under review, but its final implementation remains uncertain. The potential for a rise in organized crime has added to the controversy surrounding the administration’s efforts.